Background: As the demand for nipple-sparing mastectomy (NSM) increases and surgeons expand the eligibility criteria, a subset of patients may become candidates following neoadjuvant chemotherapy (NACT). However, the impact of NACT on postoperative complications remains unclear as the current literature is discordant.
Methods: A single-institution, retrospective chart review was performed on patients undergoing NSM from 1989 to 2017.